Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05289492 · TERMINATED
Trial details
- NCT number
- NCT05289492
- Sponsor
- iTeos Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-11-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.